Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Martin Wohlrab
Institution:
Teva Pharmaceuticals (Israel)
Observed institutions:
Teva Pharmaceuticals (Israel),
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology,
University of Tübingen
ORCID:
0009-0003-2914-4550
Observed ORCID:
0009-0003-2914-4550
OpenAlex ID:
A5042048268
Mobilise-D insights to estimate real-world walking speed in multiple conditions with a wearable device
2024
·
Cameron Kirk
, Arne Küderle
, et al.
·
Scientific Reports
·
92
The value of walking: a systematic review on mobility and healthcare costs
2022
·
Martin Wohlrab
, Jochen Klenk
, et al.
·
European Review of Aging and Physical Activity
·
28
PDF
Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?
2021
·
Simon U Jaeger
, Martin Wohlrab
, et al.
·
Age and Ageing
·
17
PDF
Mobilizing Patient and Public Involvement in the Development of Real-World Digital Technology Solutions: Tutorial
2023
·
Alison Keogh
, Ríona Mc Ardle
, et al.
·
Journal of Medical Internet Research
·
14
PDF
Author Correction: Mobilise-D insights to estimate real-world walking speed in multiple conditions with a wearable device
2024
·
Cameron Kirk
, Arne Küderle
, et al.
·
Scientific Reports
·
6
Medizinische Spracherkennung im stationären und ambulanten Einsatz – Eine systematische Übersicht
2020
·
Matthias Zuchowski
, Aydan Pashayeva
, et al.
·
Gesundheitsökonomie & Qualitätsmanagement
·
3
Correction to: Mobilise-D insights to estimate real-world walking speed in multiple conditions with a wearable device (Scientific Reports, (2024), 14, 1, (1754), 10.1038/s41598-024-51766-5)
2024
·
Cameron Kirk
, Arne Küderle
, et al.
·
Newcastle University ePrints (Newcastle Univesity)
Show more works
View as search
Works count:
7
Citation count:
160
H-index:
5
I10-index:
4
Year
Topic
Type